Cell cycle machinery and stroke

被引:87
作者
Rashidian, J. [1 ]
Iyirhiaro, G. O. [1 ]
Park, D. S. [1 ]
机构
[1] Univ Ottawa, Ottawa Hlth Res Inst, Neurosci Grp, Ctr Stroke Recovery, Ottawa, ON K1H 8M5, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2007年 / 1772卷 / 04期
基金
加拿大健康研究院;
关键词
stroke; CDKs; cyclins; cell cycle; apoptosis;
D O I
10.1016/j.bbadis.2006.11.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stroke results from a transient or permanent reduction in blood flow to the brain. The mechanisms involving neuronal death following ischemic insult are complex and not fully understood. One signal which may control ischemic neuronal death is the inappropriate activation of cell cycle regulators including cyclins, cyclin dependent kinases (CDKs) and endogenous cyclin dependent kinase inhibitors (CDKIs). In dividing cells, activation of cell cycle machinery induces cell proliferation. In the context of terminally differentiated-neurons, however, aberrant activation of these elements triggers neuronal death. Indeed, there are several lines of correlative and functional evidence supporting this "cell cycle/neuronal death hypothesis". The objective of this review is to summarize the findings implicating cell cycle machinery in ischemic neuronal death from in vitro and in vivo studies. Importantly, determining and blocking the signaling pathway(s) by which these molecules act to mediate ischemic neuronal death, in conjunction with other targets may provide a viable therapeutic strategy for stroke damage. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:484 / 493
页数:10
相关论文
共 113 条
  • [1] Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells
    Azuma-Hara, N
    Taniura, H
    Uetsuki, T
    Niinobe, M
    Yoshikawa, K
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 251 (02) : 442 - 451
  • [2] Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility
    Barber, PA
    Zhang, J
    Demchuk, AM
    Hill, MD
    Buchan, AM
    [J]. NEUROLOGY, 2001, 56 (08) : 1015 - 1020
  • [3] Bates S, 1996, ONCOGENE, V13, P1103
  • [4] Beyond proliferation - cell cycle control of neuronal survival and differentiation in the developing mammalian brain
    Becker, EBE
    Bonni, A
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (03) : 439 - 448
  • [5] Campagne MV, 1998, J NEUROSCI RES, V53, P279
  • [6] Cell cycle-related gene expression in the adult rat brain:: Selective induction of cyclin G1 and p21WAF1/CIP1 in neurons following focal cerebral ischemia
    Campagne, MV
    Gill, R
    [J]. NEUROSCIENCE, 1998, 84 (04) : 1097 - 1112
  • [7] Role of the cell cycle in the pathobiology of central nervous system trauma
    Cernak, I
    Stoica, B
    Byrnes, KR
    Di Giovanni, S
    Faden, AI
    [J]. CELL CYCLE, 2005, 4 (09) : 1286 - 1293
  • [8] THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN
    CHELLAPPAN, SP
    HIEBERT, S
    MUDRYJ, M
    HOROWITZ, JM
    NEVINS, JR
    [J]. CELL, 1991, 65 (06) : 1053 - 1061
  • [9] Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation
    Cicero, S
    Herrup, K
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (42) : 9658 - 9668
  • [10] Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase
    deAzevedo, WF
    MuellerDieckmann, HJ
    SchulzeGahmen, U
    Worland, PJ
    Sausville, E
    Kim, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2735 - 2740